<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>GBIHealth | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-10-28T23:26:35+08:00</updated>
  <subtitle>GBI专注于中国市场，为药企、器械企业和其他服务提供商建立多元的市场情报解决方案组合。GBI的高附加值行业信息、新闻和数据服务能力帮助个人和组织做出以数据为驱动的决策，更高效地沟通。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>进博会又双叒来了，亮点抢先看！第一波儿剧透：默沙东、礼来、拜耳、BMS、BI</title>
    <updated>2020-10-27T23:47:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/3AdCMiD5yUzIXo2ZjjQwkA</id>
    <link href="https://mp.weixin.qq.com/s/3AdCMiD5yUzIXo2ZjjQwkA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>基石药业达成13亿美元药物授权交易；礼来联合多家药店发布科普读物；先声药业登陆港交所</title>
    <updated>2020-10-27T23:47:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/EPJRNA5m4c171mlTfEp7bw</id>
    <link href="https://mp.weixin.qq.com/s/EPJRNA5m4c171mlTfEp7bw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 臻和科技完成超10亿元E轮融资；启明医疗TriGUARD3注册临床研究达主要安全性终点</title>
    <updated>2020-10-27T23:47:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/5D7ovCk_uNPTV4wcF31vfw</id>
    <link href="https://mp.weixin.qq.com/s/5D7ovCk_uNPTV4wcF31vfw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>外媒：美国药品降价，或将生物技术主导地位拱手让于中国？</title>
    <updated>2020-10-26T21:38:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/eCRu-_kqgRkskbTlk-bxWw</id>
    <link href="https://mp.weixin.qq.com/s/eCRu-_kqgRkskbTlk-bxWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>拜耳40亿美元收购Asklepios；GSK与爱康集团达成合作；富士胶片与国内公司合作销售法匹拉韦</title>
    <updated>2020-10-26T21:38:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/ObIyBhT9Ndh-_TFGv7Wcxg</id>
    <link href="https://mp.weixin.qq.com/s/ObIyBhT9Ndh-_TFGv7Wcxg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 9月86个医疗器械产品获批，含罗氏诊断、强生等33个进口产品；联新完成3亿元战略融资</title>
    <updated>2020-10-26T21:38:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/s01AGkOO7QphmzosUXczVg</id>
    <link href="https://mp.weixin.qq.com/s/s01AGkOO7QphmzosUXczVg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田与多家数字化创新平台达成合作；灵北中国药物开发团队负责人调整；FDA正式批准瑞德西韦治疗新冠</title>
    <updated>2020-10-25T21:52:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-25:/s/_77VgBUuoZ5qfcUsI6Se5A</id>
    <link href="https://mp.weixin.qq.com/s/_77VgBUuoZ5qfcUsI6Se5A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 阿斯利康智能辅助非小细胞肺癌PD-L1判读软件获批上市；南华干细胞转化与湖南医药达成合作</title>
    <updated>2020-10-25T21:52:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-25:/s/u1t9q-S49Vd_OF6MJYGBmQ</id>
    <link href="https://mp.weixin.qq.com/s/u1t9q-S49Vd_OF6MJYGBmQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布注射剂一致性评价相关通知；荣昌生物即将在港交所IPO；亚盛医药、宜明昂科、海王生物最新药物动态</title>
    <updated>2020-10-22T17:29:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-22:/s/ucfwNccjDFW74bEv5_bbww</id>
    <link href="https://mp.weixin.qq.com/s/ucfwNccjDFW74bEv5_bbww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>会议精选 | 2020中国新药CMC高峰论坛</title>
    <updated>2020-10-22T17:29:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-22:/s/oOEBPCOBBXPN0Y9h1VpxyQ</id>
    <link href="https://mp.weixin.qq.com/s/oOEBPCOBBXPN0Y9h1VpxyQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DRG全国推进执行？利好带量采购品种，辅助用药、高值耗材恐遭灭顶之灾</title>
    <updated>2020-10-21T17:40:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-21:/s/uTm0qTibYl8guA4D1ifT0w</id>
    <link href="https://mp.weixin.qq.com/s/uTm0qTibYl8guA4D1ifT0w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>旭化成和维健医药达成合作；CDE发布仿制药重磅政策；强生、复星、恒瑞最新药物动态</title>
    <updated>2020-10-21T17:40:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-21:/s/TsXv6Ef_yZIba_1mVLwVug</id>
    <link href="https://mp.weixin.qq.com/s/TsXv6Ef_yZIba_1mVLwVug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 药监局调整部分体外诊断产品分类；蓝帆医疗冠脉支架获CE证书</title>
    <updated>2020-10-21T17:40:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-21:/s/L4dINQ6TzXvCZY-nX4R5mA</id>
    <link href="https://mp.weixin.qq.com/s/L4dINQ6TzXvCZY-nX4R5mA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药品盈利靠新品，器械求新保增长 CMEF2020进行中，哪些新鲜内容引发思考？</title>
    <updated>2020-10-20T22:44:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-20:/s/RgCYWPCcGB88HWbnPw-J9A</id>
    <link href="https://mp.weixin.qq.com/s/RgCYWPCcGB88HWbnPw-J9A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>拜耳与美团达成合作；华东医药达成3亿美元授权交易；齐鲁制药获一高血压药物独家权益</title>
    <updated>2020-10-20T22:44:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-20:/s/BsLZmHzT70v03EC0mdqKlA</id>
    <link href="https://mp.weixin.qq.com/s/BsLZmHzT70v03EC0mdqKlA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>财报解析 | 恒瑞医药2020年Q3财报：收入超194亿元，加大研发投入，增强国际合作</title>
    <updated>2020-10-20T22:44:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-20:/s/jHN-7LMDby5sqli9Sj-z-w</id>
    <link href="https://mp.weixin.qq.com/s/jHN-7LMDby5sqli9Sj-z-w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>带量采购＝裁裁裁？85%的企业已成功“自救”</title>
    <updated>2020-10-19T22:38:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-19:/s/63V5BLUgW2xQYoT6yWwNPA</id>
    <link href="https://mp.weixin.qq.com/s/63V5BLUgW2xQYoT6yWwNPA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>影响医药行业！两大重磅法律即将施行；卫材提交癫痫药物两项新药补充申请；基石药业PD-L1获FDA 孤儿药资格认定</title>
    <updated>2020-10-19T22:38:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-19:/s/xedpEp4Ae6zHeGaM_dUqUQ</id>
    <link href="https://mp.weixin.qq.com/s/xedpEp4Ae6zHeGaM_dUqUQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>会议精选 | 2020中国新药CMC高峰论坛</title>
    <updated>2020-10-19T22:38:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-19:/s/wuzz-Vw9w3SuRKag6aMGjQ</id>
    <link href="https://mp.weixin.qq.com/s/wuzz-Vw9w3SuRKag6aMGjQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>又一款艾滋病新药上市在即！复宏汉霖达成 4300 万美元授权交易；医保目录调整最新进展；罗氏、拜耳、康方生物最新药物动态</title>
    <updated>2020-10-18T21:04:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-18:/s/AHRr8cbWbivPbMP1BlUJZA</id>
    <link href="https://mp.weixin.qq.com/s/AHRr8cbWbivPbMP1BlUJZA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>